CUSIP: 60463E103
Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,670,121
-
Share change
-
-464,435
-
Total reported value
-
$44,453,419
-
Price per share
-
$3.03
-
Number of holders
-
54
-
Value change
-
-$2,301,375
-
Number of buys
-
26
-
Number of sells
-
21
Quarterly Holders Quick Answers
What is CUSIP 60463E103?
CUSIP 60463E103 identifies MGEN - MIRAGEN THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2019
-
Previous quarter:
Q3 2018
Recent filing periods for CUSIP 60463E103:
Institutional Holders of MIRAGEN THERAPEUTICS INC - COM (MGEN) as of Q4 2018
As of 31 Dec 2018,
MIRAGEN THERAPEUTICS INC - COM (MGEN) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,670,121 shares.
The largest 10 holders included
Atlas Venture Advisors, Inc., FMR LLC, 683 Capital Management, LLC, BlackRock Inc., Samsara BioCapital, LLC, Artal Group S.A., Vanguard Group Inc, JPMORGAN CHASE & CO, Opaleye Management Inc., and STATE STREET CORP.
This page lists
54
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.